1. Adam DC, Wu P, Wong JY, Lau EHY, Tsang TK, Cauchemez S, et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nature Medicine. 2020;26(11):1714-9.
2. Lemieux JE, Siddle KJ, Shaw BM, Loreth C, Schaffner SF, Gladden-Young A, et al. Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events. Science. 2021;371(6529):eabe3261.
3. Endo A, Abbott S, Kucharski AJ, Funk S. Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China. Wellcome Open Res. 2020;5:67.
4. Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill. 2015;20(25):7-13.
5. Cho SY, Kang J-M, Ha YE, Park GE, Lee JY, Ko J-H, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. The Lancet. 2016;388(10048):994-1001.
6. Wang SX, Li Y, Sun B, Zhang S, Zhao W, Wei M, et al. The SARS outbreak in a general hospital in Tianjin, China–the case of super-spreader. Epidemiology & Infection. 2006;134(4):786-91.
7. Sun K, Wang W, Gao L, Wang Y, Luo K, Ren L, et al. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2021;371(6526):eabe2424.
8. Du Z, Wang C, Liu C, Bai Y, Pei S, Adam DC, et al. Superspreading of SARS-CoV-2 infections: A Systematic Review and Meta-analysis. medRxiv. 2021:2021.12.09.21267507.
9. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355-9.
10. Galvani AP, May RM. Dimensions of superspreading. Nature. 2005;438(7066):293-5.
11. Hébert-Dufresne L, Althouse BM, Scarpino SV, Allard A. Beyond R 0: heterogeneity in secondary infections and probabilistic epidemic forecasting. Journal of the Royal Society Interface. 2020;17(172):20200393.
12. Althaus CL. Ebola superspreading. The Lancet Infectious Diseases. 2015;15(5):507-8.
13. Sneppen K, Nielsen BF, Taylor RJ, Simonsen L. Overdispersion in COVID-19 increases the effectiveness of limiting nonrepetitive contacts for transmission control. Proceedings of the National Academy of Sciences. 2021;118(14):e2016623118.
14. Frieden TR, Lee CT. Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020;26(6):1059-66.
15. Lim J-S, Noh E, Shim E, Ryu S. Temporal Changes in the Risk of Superspreading Events of Coronavirus Disease 2019. Open Forum Infectious Diseases. 2021;8(7).
16. Lau MSY, Grenfell B, Thomas M, Bryan M, Nelson K, Lopman B. Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proceedings of the National Academy of Sciences. 2020;117(36):22430.
17. Yu ITS, Li Y, Wong TW, Tam W, Chan AT, Lee JHW, et al. Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus. New England Journal of Medicine. 2004;350(17):1731-9.
18. Blumberg S, Lloyd-Smith JO. Inference of R 0 and transmission heterogeneity from the size distribution of stuttering chains. PLoS computational biology. 2013;9(5):e1002993.
19. Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020;8(4):e488-e96.
20. Gu H, Xie R, Adam DC, Tsui JL-H, Chu DK, Chang LD, et al. SARS-CoV-2 under an elimination strategy in Hong Kong. medRxiv. 2021.
21. Laxminarayan R, Wahl B, Dudala Shankar R, Gopal K, Mohan BC, Neelima S, et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science. 2020;370(6517):691-7.
22. Miller D, Martin MA, Harel N, Tirosh O, Kustin T, Meir M, et al. Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel. Nature Communications. 2020;11(1):5518.
23. Peacock TP, Sheppard CM, Brown JC, Goonawardane N, Zhou J, Whiteley M, et al. The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin. bioRxiv. 2021:2021.05.28.446163.
24. Liu Y, Liu J, Johnson BA, Xia H, Ku Z, Schindewolf C, et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. bioRxiv. 2021:2021.08.12.456173.
25. Torjesen I. Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ. 2021;375:n2943.
26. Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022.
27. Wu P, Tsang TK, Wong JY, Ng TW, Ho F, Gao H, et al. Suppressing COVID-19 transmission in Hong Kong: an observational study of the first four months. 2020.